EBCN Meeting Budapest, 24 September 2004 Update on individual data monitoring projects QT and SEED Antonio Ponti CPO Piemonte Torino, Italy

Embed Size (px)

DESCRIPTION

SEED and QT Audit Systems 2) to provide a service to screening programmes and Breast Units to meet their management and evaluation needs.

Citation preview

EBCN Meeting Budapest, 24 September 2004 Update on individual data monitoring projects QT and SEED Antonio Ponti CPO Piemonte Torino, Italy SEED and QT Audit Systems Their aim is two-fold: 1) to favour the implementation of European Guidelines (with training and certification implications), and SEED and QT Audit Systems 2) to provide a service to screening programmes and Breast Units to meet their management and evaluation needs. Advantages of monitoring Individual vs Aggregate screening data (1) - Use of common definitions and rules in the process of collecting the minimum dataset: an educational process Advantages of monitoring Individual vs Aggregate screening data (2) - Standard analysis of common dataset, including standard reports on European outcome measures Advantages of monitoring Individual vs Aggregate screening data (3) - Much more flexible analytical approach Projects and Partners (6 Countries) To access SEED (on line)demo has about 100,000 screening episodes SEED Results Seven European programmes % Technical repeat rate 1.8 IM after assessment 1.6 Invasive Ca E.G. standard < 1.0 > 30.0 % 124,555 FIRST TESTS 159,511 SUBS. TESTS % < 3.0 < 1.0 Further assessment rate < 7.0 < 3.0 < 0.5 < 0.2 To download QT Assessment Episodes Operated lesions Total 5,513 1, No No Valencia Torino Strasbourg Ravenna Marseille Luxembourg London Leuven Firenze Bremen Center Wiesbaden 50-Budapest 67,8 80,3 99,5 52,9 90,3 87,9 89,1 88,3 89,4 77,0 34,2 99,8 99,1 61,3 YESNO Result % QT outcome measures 92,4 80,2 88,4 88,1 46,3 13,3 64,8 62,5 66,0 68,1 51, Positive preoperative cyto/histolog. diagnosis Cancers with post-operative diagnosis YES?NO Results % CENTER 92,4 80,2 88,4 88,1 46,3 13,3 64,8 62,5 66,0 68,1 51, Positive preoperative cyto/histolog. diagnosis Cancers with post-operative diagnosis YESNO Results % CENTER FNA & Core biopsy (operated only) FNA?NoneBothCB CENTER Fine Needle Aspiration Absolute Sensitivity Full Specificity Pre-operative diagnosis Absolute Sensitivity Full Specificity Time btw screening and assessment